Christopher Lewis Stone, VP, General Counsel & Secretary at PDL BIOPHARMA, INC. (PDLI), sold 200,000 shares at $2.56 ($512K) on 2020-12-16, disclosed to the SEC on 2020-12-17.
Seasonal sale ($512k) by VP, General Counsel & Secretary — this insider has traded PDLI in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.